SCHEMBL23927586

SCHEMBL23927586

CC(C)(C)c1ccc(Nc2ccc3c(c2)C(C)(C)c2ccccc2C3(C)C)c(-c2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNK18 Q7Z418 1/20 0.36
▸ ABCG2 Q9UNQ0 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ AKR1C3 P42330 2/20 0.33
▸ AKR1C2 P52895 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ CASP3 P42574 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ SENP8 Q96LD8 2/20 0.33
▸ SENP7 Q9BQF6 2/20 0.33
▸ SENP6 Q9GZR1 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ PLA2G1B P04054 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ ATG4B Q9Y4P1 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PTGS1 P23219 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24772229 0.95 KCNK18 (0.36) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL25810334 0.94 KCNK18 (0.35) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL26599461 0.90 PDK2 (0.39) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL30363478 0.90 KCNK18 (0.37) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL30363263 0.90 PDK2 (0.39) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL22934074 0.85 CYP26A1 (0.40) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL25125106 0.84 KCNK18 (0.38) KCNK18ABCG2ALDH1A1NPC1CASP3
SCHEMBL25810318 0.83 JAK2 (0.34) AKR1C3AKR1C2MEN1KMT2A
SCHEMBL23118189 0.82 AKR1C3 (0.46) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2
SCHEMBL30503054 0.82 AKR1C3 (0.46) KCNK18ABCG2ALDH1A1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497415-B2 Polycyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2025-12-16 — — US disclosed
US-20230077439-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2023-03-16 — — US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 — — US disclosed
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2022-12-15 — — US disclosed
CN-113875033-A Organic light emitting device 株式会社LG化学 2021-12-31 — — CN disclosed
CN-113646915-A Organic light emitting device 株式会社LG化学 2021-11-12 — — CN disclosed
EP-3901158-A2 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG Chem, Ltd. (KR) 2021-10-27 — — EP disclosed
CN-113396151-A Polycyclic compound and organic light-emitting element comprising same 株式会社LG化学 2021-09-14 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT CYBA, CRY1, CYP1A1 KCNK18 3543/4885ABCG2 2551/4885ALDH1A1 94/4885
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT CYP1A1, AHR, CYP1B1 KCNK18 3411/4885ABCG2 1849/4885ALDH1A1 145/4885
US-20230077439-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CYBA, CRY2, CRY1 KCNK18 1843/4885ABCG2 2354/4885ALDH1A1 2139/4885
US-12497415-B2 Polycyclic compound and organic light-emitting element comprising same CYBA, CRY2, CRY1 KCNK18 1843/4885ABCG2 2354/4885ALDH1A1 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback